Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma

NCT00848328 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Lymphoma

Interventions

BIOLOGICAL: Rituximab
DRUG: Lenalidomide

Sponsor

University of California, Davis

Collaborators

[object Object]